Imodium Instant

Loperamide, the active ingredient in Imodium Instant, is an opioid antidiarrheal presented as an oral tablet for oral use. It reduces intestinal motility and secretion, providing symptomatic relief of acute nonspecific diarrhea, travelers' diarrhea, and chronic diarrhea associated with inflammatory bowel disease in adults and children over two years of age.

GNH USA supplies Imodium Instant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Imodium Instant (loperamide) is used to manage diarrheal conditions by slowing intestinal transit. - Acute nonspecific diarrhea: reduces stool frequency and improves consistency. - Travelers' diarrhea: provides rapid symptom relief for travelers experiencing acute gastrointestinal upset. - Chronic diarrhea associated with inflammatory bowel disease: helps control stool output in patients with IBD‑related diarrhea.

Loperamide may cause a range of adverse reactions, most of which are mild and dose‑related.

Common Side Effects: - Constipation: hard stools or reduced bowel movements. - Abdominal cramps: mild to moderate discomfort in the abdomen. - Nausea: feeling of sickness or urge to vomit. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Severe constipation leading to bowel obstruction: abdominal pain, vomiting, inability to pass stool. - Paralytic ileus: marked loss of intestinal motility requiring medical attention. - Cardiac arrhythmias: irregular heart rhythm, especially with high doses or drug interactions.

When using Imodium Instant, several safety considerations should be observed to minimize risks. - Assess underlying cause: ensure diarrhea is not due to infection requiring antimicrobial therapy. - Limit duration: do not exceed 48 hours of continuous use without medical review. - Monitor dehydration: maintain adequate fluid and electrolyte intake during treatment. - Caution in hepatic impairment: dose may need adjustment in patients with liver disease. - Avoid in children under two years: not recommended for infants younger than two years of age. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Loperamide can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase loperamide plasma levels and risk of cardiac toxicity. - P‑glycoprotein inhibitors (e.g., quinidine, ritonavir): can raise systemic exposure, heightening adverse effect risk. - Opioid agonists: additive central opioid effects may increase sedation or respiratory depression.

Moderate Interactions (Monitor Closely): - Antidiarrheal agents (e.g., diphenoxylate): combined effect may cause excessive slowing of gut motility. - Anticholinergic drugs: may enhance constipation. - Certain antidepressants (e.g., amitriptyline): potential for additive CNS depression.